Ladenburg Thalmann & Co. Inc. acted as exclusive placement agent for the offerings.

Erez Meltzer; Chief Executive Officer, Director; Nano-X Imaging Ltd Ran Daniel; Chief Financial Officer; Nano-X Imaging Ltd Jeffrey Cohen; Analyst; Ladenburg Thalmann & Co. Inc. Ross Osborn; Analyst; ...

Fintel reports that on March 19, 2025, Ladenburg Thalmann downgraded their outlook for Public Service Enterprise Group ...

B2i Digital will showcase AI-focused innovators ahead of the May 21, 2025, event in New York City, facilitating connections between forward-thinking companies and strategic investors NEW YORK, NY - ...

Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to Neutral. Analyst Price Forecast Suggests 361.36% Upside As of March 4, 2025, ...

Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it ...

Fintel reports that on March 19, 2025, Ladenburg Thalmann downgraded their outlook for Public Service Enterprise Group (BMV:PEG) from Buy to Neutral. There are 1,591 funds or institutions ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company advancing targeted immunotherapies, has entered into a securiti ...

("Osaic"), one of the nation's largest providers of wealth management solutions, today announced that Ever Wealth, an Auburn, Indiana-based advisory firm with more than $170 million in client assets, ...

Discover Corvus Pharmaceuticals' Q4 2024 earnings insights, highlighting soquelitinib's trial progress, upcoming milestones for 2025, and robust ...